CDX cardiex limited

2.50%

3.9¢

He also reckons he rang the hospital and they told him that the...

First 333 Last

Share
Profile

Follow
dante

2,089 Posts.

51

11/03/19

15:01

Post #: 37721311
Share

Originally posted by imback ↑

Well that's a very interesting find. It's the first time I've seen an independent industry expert call out CDX technology as a potentially very significant player in the wearable space.

I think he gets what they are trying to do with Blumio which is effectively a cuffless calibrated BP - the holy grail of BP measurements. Add in the CDX's PWA capabilities and you have a whole host of fitness and health indicators on a wearable which Apple and Samsung do not have on their devices and won't be able to do with their current sensor technologies.

I had a read posts from the clown on Twitter re Blumio and there already being cuffless BP out there. He probably needs to spend a few more minutes googling to understand the difference between what Blumio/Cardiex are doing compared to the market and current technologies. He claims Blumio will not make a profit for many years. Blumio will be taken out in a flash if they prove the technology. They will never have a chance to make a profit or even do a commercial production run.

Expand

He also reckons he rang the hospital and they told him that the trial was on hold. Anyone here ever try to get an answer from a hospital about something, seriously!!!!! - they are going to discuss something like that with just someone who rings them out of the blue.

Anyway, I'm more interested in the GEMDC's name and product launch announcement at this stage.

CDX Price at posting: 4.6¢ Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

First 333 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 3.9¢		Change -0.001(2.50%)		Mkt cap ! $17.49M

Open	High	Low	Value	Volume
3.9¢	4.0¢	3.8¢	$20.01K	521.6K

Buyers (Bids)

No.	Vol.	Price($)
2	75000	3.8¢

Sellers (Offers)

Price($)	Vol.	No.
4.2¢	60000	1

View Market Depth

No.	Vol.	Price($)
2	75000	0.038
5	677100	0.037
2	263210	0.036
4	515503	0.035
3	382970	0.034

Price($)	Vol.	No.
0.042	60000	1
0.045	82414	2
0.050	100000	1
0.052	180000	1
0.080	100799	1

Last trade - 15.40pm 27/06/2025 (20 minute delay)

CDX (ASX) Chart

He also reckons he rang the hospital and they told him that the...

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

He also reckons he rang the hospital and they told him that the...

Top Stories

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Monash IVF shares cater 25% – Disaster or deep-value play?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News